Literature DB >> 19328042

A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death.

Hubert Pan1, Ashleigh A Richards, Xiaohui Zhu, Jose A Joglar, Helen L Yin, Vidu Garg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328042      PMCID: PMC2701154          DOI: 10.1016/j.hrthm.2009.01.037

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  17 in total

1.  Primary prevention of sudden death in patients with lamin A/C gene mutations.

Authors:  Christophe Meune; Jop H Van Berlo; Frédéric Anselme; Gisèle Bonne; Yigal M Pinto; Denis Duboc
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

Review 2.  Begetting atrial fibrillation: Connexins and arrhythmogenesis.

Authors:  Michael H Gollob
Journal:  Heart Rhythm       Date:  2007-12-04       Impact factor: 6.343

3.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Authors:  D Fatkin; C MacRae; T Sasaki; M R Wolff; M Porcu; M Frenneaux; J Atherton; H J Vidaillet; S Spudich; U De Girolami; J G Seidman; C Seidman; F Muntoni; G Müehle; W Johnson; B McDonough
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

Review 4.  The laminopathies: a clinical review.

Authors:  J Rankin; S Ellard
Journal:  Clin Genet       Date:  2006-10       Impact factor: 4.438

5.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.

Authors:  Timothy M Olson; Virginia V Michels; Jeffrey D Ballew; Sandra P Reyna; Margaret L Karst; Kathleen J Herron; Steven C Horton; Richard J Rodeheffer; Jeffrey L Anderson
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

6.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

Authors:  Jop H van Berlo; Willem G de Voogt; Anneke J van der Kooi; J Peter van Tintelen; Gisèle Bonne; Rabah Ben Yaou; Denis Duboc; Tom Rossenbacker; Hein Heidbüchel; Marianne de Visser; Harry J G M Crijns; Yigal M Pinto
Journal:  J Mol Med (Berl)       Date:  2004-11-13       Impact factor: 4.599

7.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

8.  Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.

Authors:  P Sébillon; C Bouchier; L D Bidot; G Bonne; K Ahamed; P Charron; V Drouin-Garraud; A Millaire; G Desrumeaux; A Benaïche; J-C Charniot; K Schwartz; E Villard; M Komajda
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

9.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.

Authors:  G Bonne; M R Di Barletta; S Varnous; H M Bécane; E H Hammouda; L Merlini; F Muntoni; C R Greenberg; F Gary; J A Urtizberea; D Duboc; M Fardeau; D Toniolo; K Schwartz
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

10.  Lamin A/C truncation in dilated cardiomyopathy with conduction disease.

Authors:  Heather M MacLeod; Mary R Culley; Jill M Huber; Elizabeth M McNally
Journal:  BMC Med Genet       Date:  2003-07-10       Impact factor: 2.103

View more
  21 in total

1.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 2.  Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Subha V Raman; Cristina Basso; Harikrishna Tandri; Matthew R G Taylor
Journal:  Circ Cardiovasc Imaging       Date:  2010-11       Impact factor: 7.792

Review 3.  Arrhythmias as Presentation of Genetic Cardiomyopathy.

Authors:  J Lukas Laws; Megan C Lancaster; M Ben Shoemaker; William G Stevenson; Rebecca R Hung; Quinn Wells; D Marshall Brinkley; Sean Hughes; Katherine Anderson; Dan Roden; Lynne W Stevenson
Journal:  Circ Res       Date:  2022-05-26       Impact factor: 23.213

4.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

Review 5.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

6.  Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.

Authors:  Nazish Sayed; Chun Liu; Mohamed Ameen; Farhan Himmati; Joe Z Zhang; Saereh Khanamiri; Jan-Renier Moonen; Alexa Wnorowski; Linling Cheng; June-Wha Rhee; Sadhana Gaddam; Kevin C Wang; Karim Sallam; Jack H Boyd; Y Joseph Woo; Marlene Rabinovitch; Joseph C Wu
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

7.  Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown Cause.

Authors:  Johnni Resdal Dyssekilde; Tanja Charlotte Frederiksen; Morten Krogh Christiansen; Rikke Hasle Sørensen; Lisbeth Nørum Pedersen; Peter Loof Møller; Lene Svendstrup Christensen; Jacob Moesgaard Larsen; Kristian Korsgaard Thomsen; Tommi Bo Lindhardt; Morten Böttcher; Stig Molsted; Ole Havndrup; Thomas Fischer; Dorthe Svenstrup Møller; Finn Lund Henriksen; Jens Brock Johansen; Jens Cosedis Nielsen; Henning Bundgaard; Mette Nygaard; Henrik Kjærulf Jensen
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

Review 8.  Personalized medicine and atrial fibrillation: will it ever happen?

Authors:  Steven A Lubitz; Patrick T Ellinor
Journal:  BMC Med       Date:  2012-12-04       Impact factor: 8.775

9.  Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.

Authors:  Chung-Wah Siu; Yee-Ki Lee; Jenny Chung-Yee Ho; Wing-Hon Lai; Yau-Chi Chan; Kwong-Man Ng; Lai-Yung Wong; Ka-Wing Au; Yee-Man Lau; Jinqiu Zhang; Kenneth Weijian Lay; Alan Colman; Hung-Fat Tse
Journal:  Aging (Albany NY)       Date:  2012-11       Impact factor: 5.682

10.  Whole-exome sequencing to identify a novel LMNA gene mutation associated with inherited cardiac conduction disease.

Authors:  Chun-Chi Lai; Yung-Hsin Yeh; Wen-Ping Hsieh; Chi-Tai Kuo; Wen-Ching Wang; Chia-Han Chu; Chiu-Lien Hung; Chia-Yang Cheng; Hsin-Yi Tsai; Jia-Lin Lee; Chuan-Yi Tang; Lung-An Hsu
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.